Showing results (101-110 of 186) with videos related to

Sort By:
Pageof 19
Plos One|November 19, 2014
Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics studyAmanda Worker, Camilla Blain, Jozef Jarosz, et al.
Human Molecular Genetics|October 24, 2002
Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transportJanet Brownlees, Steven Ackerley, Andrew J Grierson, et al.
Rheumatology (Oxford, England)|December 21, 2013
Circulating T follicular helper cell and regulatory T cell frequencies are influenced by B cell depletion in patients with granulomatosis with polyangiitisYuan Zhao, Pamela M K Lutalo, Jessica E Thomas, et al.
International Journal of Molecular Sciences|March 25, 2022
The Expression of Active CD11b Monocytes in Blood and Disease Progression in Amyotrophic Lateral SclerosisOzlem Yildiz, Johannes Schroth, Vittoria Lombardi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 19, 2022
Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis CohortsRubika Balendra, Ashley R Jones, Ahmad Al Khleifat, et al.
Trials|May 18, 2022
INNODIA Master Protocol for the evaluation of investigational medicinal products in children, adolescents and adults with newly diagnosed type 1 diabetesDavid B Dunger, Sylvaine F A Bruggraber, Adrian P Mander, et al.
Brain Communications|July 3, 2020
Identification of a potential non-coding RNA biomarker signature for amyotrophic lateral sclerosisGreig Joilin, Elizabeth Gray, Alexander G Thompson, et al.
Lancet (London, England)|December 26, 2008
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyJean-Philippe Collet, Jean-Sébastien Hulot, Anna Pena, et al.
Diabetes|June 22, 2019
Standardizing T-Cell Biomarkers in Type 1 Diabetes: Challenges and Recent AdvancesSimi Ahmed, Karen Cerosaletti, Eddie James, et al.
Lancet (London, England)|May 12, 2025
Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, P Nigel Leigh, Timothy Tree, et al.
Pageof 19